| First Author | Ingle H | Year | 2023 |
| Journal | Sci Adv | Volume | 9 |
| Issue | 37 | Pages | eadi2562 |
| PubMed ID | 37703370 | Mgi Jnum | J:340288 |
| Mgi Id | MGI:7528097 | Doi | 10.1126/sciadv.adi2562 |
| Citation | Ingle H, et al. (2023) IFN-lambda derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus. Sci Adv 9(37):eadi2562 |
| abstractText | Norovirus is a leading cause of epidemic viral gastroenteritis, with no currently approved vaccines or antivirals. Murine norovirus (MNoV) is a well-characterized model of norovirus pathogenesis in vivo, and persistent strains exhibit lifelong intestinal infection. Interferon-lambda (IFN-lambda) is a potent antiviral that rapidly cures MNoV. We previously demonstrated that IFN-lambda signaling in intestinal epithelial cells (IECs) controls persistent MNoV, and here demonstrate that IFN-lambda acts on tuft cells, the exclusive site of MNoV persistence, to limit infection. While interrogating the source of IFN-lambda to regulate MNoV, we confirmed that MDA5-MAVS signaling, required for IFN-lambda induction to MNoV in vitro, controls persistent MNoV in vivo. We demonstrate that MAVS in IECs and not immune cells controls MNoV. MAVS in nonsusceptible enterocytes, but not in tuft cells, restricts MNoV, implicating noninfected cells as the IFN-lambda source. Our findings indicate that host sensing of MNoV is distinct from cellular tropism, suggesting intercellular communication between IECs for antiviral signaling induction in uninfected bystander cells. |
